Current portfolio
Egle Therapeutics
Egle is developing a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Treg starving
- SektorHealthcare
- LandFrance
- FondLSP 7
- Entry2021
- Web

- SektorHealthcare
- LandFrance
- FondLSP 7
- Entry2021
- Web